RxDoctor Payments Data

Dustin Hawley, MD

Family Medicine · Borger, TXNPI 1831416015

Payments from drug & device makers

$1,043in general payments, 2019–2025

Across 58 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$218
  • Lilly USA, LLC$127
  • Sanofi-aventis U.S. LLC$76
  • AstraZeneca$74
  • GSK$70
  • Boehringer Ingelheim$65
  • plus $412 from 16 others

What the payments were for

  • Food & beverage$1,043100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,043 in reported general payments places this provider in the 60th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$63,469
Medicare patients
179
Services billed
1,023

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide54$63,578
OzempicSemaglutide45$42,570
FarxigaDapagliflozin Propanediol26$32,329
EliquisApixaban25$26,105
Trelegy ElliptaFluticasone/Umeclidin/Vilanter34$21,289
JardianceEmpagliflozin30$20,839
Tresiba Flextouch U-100Insulin Degludec14$14,551
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$7,356
Pantoprazole Sodium81$1,260
Levothyroxine Sodium112$1,105
Losartan Potassium90$957
Lubiprostone12$871
Omeprazole58$856
Lisinopril101$792
Metoprolol Succinate48$772

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$127$63,57854 claims
Novo NordiskOzempic$15$42,57045 claims
AstraZenecaFarxiga$74$32,32926 claims
PfizerEliquis$54$26,10525 claims
GSKTrelegy Ellipta$70$21,28934 claims
Boehringer IngelheimJardiance$65$20,83930 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Borger

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →